Read more: http://www.dailymail.co.uk/health/article-2487135/Whats-YOUR-fitness-age-New-calculator-tells-youre-old-years-simple-steps.html#ixzz2jp2n17DN
By Anna Hodgekiss
[SIDEBAR: Go to this article first, in order to get instructions on how to complete the form on the calculator website--goes much faster once you understand how to proceed with it. Also, we have included the weblink in order to convert your waistline inches into centimeters.]
Calculator Weblink: http://www.ntnu.edu/cerg/vo2max
Waistline Inches converted into Centimeters Weblink: http://www.convertunits.com/from/inches/to/cm
Zilmax: Slaughterhouse Observations Raise New Concerns about This Growth-Promoting Drug
November 5, 2013
Story at-a-glance
- Zilmax is class of non-hormone drugs recently used in animals to promote growth. It, and others like it are fed to cattle in the weeks prior to slaughter to increase weight by as much as 30 pounds of lean meat per cow
- Tyson Foods announced in September that it would stop buying Zilmax-fed cattle for slaughter due to concerns about Zilmax potentially causing health or behavioral problems for some cattle
- Zilmax is already banned for use in horses due to severe side effects, including muscle tremors and rapid heart rates that can last as long as two weeks after stopping the drug
- Before beta-agonsists like Zilmax were approved, scientists worried that this class of drug could result in increased cardiovascular risk for consumers
- Merck is actively working on getting Zilmax back on the US and Canadian markets
Rep. Urges FDA to Stop Illegal NDI Copycats
November 1, 2013
Texas Rep. Steve Stockman urged FDA to take enforcement action against companies that illegally piggy back on other companies' new dietary ingredient (NDI) notifications.
The Dietary Supplement Health and Education Act of 1994 (DSHEA) requires companies submit NDI notifications to FDA 75 days before going to market in the United States. NDIs are not required when an ingredient is chemically identical to one that's already been introduced to the market, but Stockman said some companies are introducing new ingredients without notification.
"Those companies that sell these products that have submitted NDI notifications are taking positive action to ensure consumer safety, while those companies which skirt FDA requirements for NDI notification are putting consumers at risk by offering illegal versions of supplements whose ingredients have not be properly vetted by the FDA," Stockman wrote in a letter to FDA commissioner Dr. Margaret Hamburg.
Calling out three ingredients in particular, Stockman said multiple Chinese companies have introduced NDIs to the U.S. market without FDA notification. The three "reputable multinational corporations" Stockman said have been harmed by illegal competitive ingredients are Mitsubishi Gas Chemical (pyrroloquinoline [PQQ]), Fuji Health Sciences (astaxanthin) and Xsto, which is the exclusive distributor for Hamari Chemical (zinc carnasine), according to Marc Ullman, partner, Ullman, Shapiro and Ullman.
"As the letter says, we don't know the conditions under which the ingredients are made, we don't know if the people who are producing these ingredients know what they are doing, we don't know if they are able to consistently produce the same thing, and there's no assurance of control in the manufacturing process, and that creates a public health risk," said Ullman, who represents Mitsubishi, Fuji and Hamari. "It also creates a terribly unfair competitive situation."
"Those companies that sell these products that have submitted NDI notifications are taking positive action to ensure consumer safety, while those companies which skirt FDA requirements for NDI notification are putting consumers at risk by offering illegal versions of supplements whose ingredients have not be properly vetted by the FDA," Stockman wrote in a letter to FDA commissioner Dr. Margaret Hamburg.
Calling out three ingredients in particular, Stockman said multiple Chinese companies have introduced NDIs to the U.S. market without FDA notification. The three "reputable multinational corporations" Stockman said have been harmed by illegal competitive ingredients are Mitsubishi Gas Chemical (pyrroloquinoline [PQQ]), Fuji Health Sciences (astaxanthin) and Xsto, which is the exclusive distributor for Hamari Chemical (zinc carnasine), according to Marc Ullman, partner, Ullman, Shapiro and Ullman.
"As the letter says, we don't know the conditions under which the ingredients are made, we don't know if the people who are producing these ingredients know what they are doing, we don't know if they are able to consistently produce the same thing, and there's no assurance of control in the manufacturing process, and that creates a public health risk," said Ullman, who represents Mitsubishi, Fuji and Hamari. "It also creates a terribly unfair competitive situation."
While industry has asked FDA to address exactly what kind of chemical alterations would require a NDI notification, Ullman said the practice of "me too" products hasn't been address by FDA. "And this is a problem," he said. "Fuji, Hamari and Mitsubishi invested a lot of money into developing a proprietary manufacturing processes, doing safety studies and going through the NDI notification process."
In contrast, Ullman said the copycat companies did not invest as much, and they are selling their products at a much cheaper price. These companies don't have anything that shows safety data, Ullman said.
Ullman said he expects other companies and government officials to support Stockman's letter. " We are fairly certain that there are a large number of companies that are devoted to science and compliance that would welcome our efforts," he said. Ullman added a variety of other representatives in Congress and the Senate that have expressed interest in this matter; he said he hopes more will sign off on the letter.
If a company with an NDI faces a similar situation with competitors illegally entering the market, Ullman suggested they petition FDA for enforcement. His advice for FDA: "Stop it at the border if there's no NDI. Most of the offending material is imported. Don't let it into the country."
In contrast, Ullman said the copycat companies did not invest as much, and they are selling their products at a much cheaper price. These companies don't have anything that shows safety data, Ullman said.
Ullman said he expects other companies and government officials to support Stockman's letter. " We are fairly certain that there are a large number of companies that are devoted to science and compliance that would welcome our efforts," he said. Ullman added a variety of other representatives in Congress and the Senate that have expressed interest in this matter; he said he hopes more will sign off on the letter.
If a company with an NDI faces a similar situation with competitors illegally entering the market, Ullman suggested they petition FDA for enforcement. His advice for FDA: "Stop it at the border if there's no NDI. Most of the offending material is imported. Don't let it into the country."
Is fluoride slithering poison that seeps into brain?
October 28, 2013 (Ireland)http://www.londonderrysentinel.co.uk/news/local-news/is-fluoride-slithering-poison-that-seeps-into-brain-1-5631145
A LEADING anti-fluoridation campaigner argues forcefully against the introduction of the measure in today’s paper quoting former Belgian Public Health Minister, Magda Aelvoet: “Fluoride is a slithering poison that seeps into the brain.”
Public Forum on Water Fluoridation This Monday
[Sidebar: Waiting to find an update article about this!]
The City of Salina will hold an open public forum to discuss water fluoridation. Pro-fluoridation and anti-fluoridation panels will have 30 minutes each for presentations. They will then take questions and comments from the public. The forum will be moderated by Eggers & Zimmerman Law & Mediation. We encourage everyone interested in this topic to attend!
Monday, November 4
7:00 p.m. to 9:00 p.m.
City-CountyBuilding
300 West Ash
Room 107
Salina, Kansas
No comments:
Post a Comment